Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jaffe

Showing results (491-500 of 579) with videos related to

Pageof 58
Sort By:
JAMA Ophthalmology|July 25, 2014
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema, Susan B Bressler, Allison R Edwards, et al.
Ophthalmology. Retina|June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments TrialsJason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology|January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments TrialsJuan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
American Journal of Ophthalmology|November 22, 2020
Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments TrialsAvni P Finn, Maxwell Pistilli, Vincent Tai, et al.
Ophthalmology. Retina|April 11, 2022
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments TrialsJason Q Core, Maxwell Pistilli, Peiying Hua, et al.
Retina (Philadelphia, Pa.)|January 1, 1994
Postoperative fibrin formation and visual outcome after pars plana vitrectomyD P Han, Q Wang, A Hartz, et al.
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina|June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical TrialLee M Jampol, Isoken Odia, Adam R Glassman, et al.
Ophthalmology. Retina|May 15, 2022
Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration: The Importance of Outer Retinal IntegrityJoseph R Abraham, Glenn J Jaffe, Peter K Kaiser, et al.
Pageof 58

Showing results (491-500 of 579) with videos related to

Sort By:
Pageof 58
JAMA Ophthalmology|July 25, 2014
Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema, Susan B Bressler, Allison R Edwards, et al.
Ophthalmology. Retina|June 14, 2021
Predominantly Persistent Subretinal Fluid in the Comparison of Age-Related Macular Degeneration Treatments TrialsJason Q Core, Maxwell Pistilli, Ebenezer Daniel, et al.
Ophthalmology|January 13, 2017
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments TrialsJuan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, et al.
American Journal of Ophthalmology|November 22, 2020
Localized Optical Coherence Tomography Precursors of Macular Atrophy and Fibrotic Scar in the Comparison of Age-Related Macular Degeneration Treatments TrialsAvni P Finn, Maxwell Pistilli, Vincent Tai, et al.
Ophthalmology. Retina|April 11, 2022
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments TrialsJason Q Core, Maxwell Pistilli, Peiying Hua, et al.
Retina (Philadelphia, Pa.)|January 1, 1994
Postoperative fibrin formation and visual outcome after pars plana vitrectomyD P Han, Q Wang, A Hartz, et al.
Ophthalmology|October 11, 2012
Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degenerationGui-shuang Ying, Jiayan Huang, Maureen G Maguire, et al.
Ophthalmology. Retina|June 17, 2017
Visual and Morphologic Outcomes in Eyes with Hard Exudate in the Comparison of Age-Related Macular Degeneration Treatments TrialsEbenezer Daniel, Juan E Grunwald, Benjamin J Kim, et al.
Retina (Philadelphia, Pa.)|November 15, 2017
PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical TrialLee M Jampol, Isoken Odia, Adam R Glassman, et al.
Ophthalmology. Retina|May 15, 2022
Impact of Baseline Quantitative OCT Features on Response to Risuteganib for the Treatment of Dry Age-Related Macular Degeneration: The Importance of Outer Retinal IntegrityJoseph R Abraham, Glenn J Jaffe, Peter K Kaiser, et al.
Pageof 58